http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-332642-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09b75447599077b3bb8729d973ebb411
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70198e8ee482a158ad4e0762e9d77f06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ed2f41f7b8a62f65efeb2314e9b83a
publicationDate 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-332642-B1
titleOfInvention Use of picropodophylline for the preparation of a drug for the prophylaxis or treatment of Ewing's sarcoma, glioblastoma, prostate carcinoma, breast carcinoma, gastric cancer, pancreatic carcinoma, ovarian cancer and endometrial carcinoma
abstract Summary The invention refers to the use of specific cyclic ligands, wherein the carbon atoms in positions 9 and 9 'have cis configuration, for inhibiting insulin-like growth factor-1 receptor. Said compounds may be used for the treatment of IGF-1R dependent diseases such as cancer, psoriasis, atherosclerosis and acromegaly. A preferred compound is picropodophylline.
priorityDate 2001-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25718
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442951
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395889
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16001
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3480
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID453676

Total number of triples: 44.